ARC Capital in the Australia-China biotech invest

ARC Capital in the Australia-China biotech invest

Last Monday, ARC Capital was involved in the Australia-China biotech invest 2017, the place to find Biotech innovators from around the world and partnership opportunities. with leading-edge technologies.

The program took place on Monday 27 March at the Marriott in Shanghai. The program featured company presentations, keynote speakers, lively panel discussions and was the perfect location for us to meet potential clients.

We discuss with the following companies in order to cooperate together:

  • Petri Exchange
  • Biotron
  • Novogen
  • FivepHusion
  • ResApp

The upcoming partnerships is an indication of ARC Capital’s capabilities to assist both public and private listed companies.

Continue reading

Partnering for Growth: Hoenergy and Octopus Energy Sign MoU to Expand Their Digital Energy Footprint

Partnering for Growth: Hoenergy and Octopus Energy Sign MoU to Expand Their Digital Energy Footprint

Hoenergy has signed a strategic cooperation agreement with Octopus Energy, the UK-based European clean energy leader. The two companies will partner closely across energy storage equipment, digital energy technology and VPPs, combining their respective strengths in energy technology, market access, platforms and operations. Together, they aim to grow their presence in new energy markets in […]
ARC Group ramps up HK asset management arm with $100m own capital
ARC Group's 2026 Capital Markets & M&A Forum Concludes in Shanghai, Exploring New Pathways for Overseas Listings and Global Expansion
Exascale Labs Holdings Inc. Announces Closing of Business Combination with D. Boral ARC Acquisition I Corp. and Commencement of Trading on Nasdaq Under Ticker Symbol “XLAB”

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission